SCHEMBL28364263

SCHEMBL28364263

O=C(O)[C@H](CCCCC(F)(F)F)N=C(c1ccccc1)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 1/20 0.59
CYSLTR2 Q9NS75 1/20 0.36
CYSLTR1 Q9Y271 1/20 0.36
CES1 P23141 1/20 0.35
HDAC3 O15379 1/20 0.33
TSHR P16473 1/20 0.33
ALDH1A1 P00352 2/20 0.32
PPARG P37231 1/20 0.32
PPARA Q07869 1/20 0.32
MMP2 P08253 1/20 0.32
MMP9 P14780 1/20 0.32
MMP8 P22894 1/20 0.32
MMP13 P45452 1/20 0.32
KIF11 P52732 4/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ESR1 P03372 1/20 0.31
PADI1 Q9ULC6 1/20 0.31
PADI4 Q9UM07 1/20 0.31
PADI2 Q9Y2J8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18770572 1.00 AAK1 (0.59) AAK1CYSLTR2CYSLTR1CES1HDAC3
SCHEMBL28367717 1.00 AAK1 (0.59) AAK1CYSLTR2CYSLTR1CES1HDAC3
SCHEMBL16371038 0.91 AAK1 (0.68) AAK1CES1HDAC3TSHRALDH1A1
SCHEMBL28269214 0.84 AAK1 (0.65) AAK1CES1TSHRALDH1A1MMP8
SCHEMBL28367638 0.84 AAK1 (0.46) AAK1CES1TSHRALDH1A1PPARG
SCHEMBL28367899 0.84 AAK1 (0.46) AAK1CES1TSHRALDH1A1PPARG
SCHEMBL18762620 0.84 AAK1 (0.46) AAK1CES1TSHRALDH1A1PPARG
SCHEMBL18762429 0.83 AAK1 (0.86) AAK1CYSLTR2CYSLTR1TSHRALDH1A1
SCHEMBL18762427 0.83 AAK1 (0.86) AAK1CYSLTR2CYSLTR1TSHRALDH1A1
SCHEMBL18762563 0.83 AAK1 (0.86) AAK1CYSLTR2CYSLTR1TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110809467-A Modulators of SESTRIN-GATOR2 interaction and uses thereof 纳维托制药有限公司 2020-02-18 CN disclosed